New search | Conferencedetail
Print view
 
 

Immunometabolism Drug Development Summit

evvnt Platform / evvnt
-
12.02.2019 - 13.02.2019  The Colonnade Boston Hotel, 120 Huntington Avenue, 02116 Boston, USA
Time: 8:00 am - 4:00 pm
 
Conference themes
As scientific breakthroughs and novel discoveries reveal the causal link and interface between metabolic pathways and immune cell function, the inaugural Immunometabolism Drug Development Summit 2019 is dedicated to help large pharma, biotech and academia translate basic immunometabolism research into a novel class of clinically safe and effective therapeutics for immune-mediated diseases.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Laurence Turka (Rheos Medicines), Robert Wild (Dracen Pharmaceuticals), Paul-Peter Tak (Levicept and Sitryx Therapeutics), Lauriane Cabon (Roche), Mateusz Nowak (Selvita)
 

Enquiries and Registration:

https://go.evvnt.com/304815-1?pid=4832
Mr. Hanson Wade
 
Categories
Public Health
Languages
English
Congress fees
USD 899.0 - USD 2398.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Akademie der ÄrzteÄrzte der WeltHilfswerk AustriaÖsterreichisches Rotes KreuzAMREF - African Medical and Research FoundationnewTreeÖsterreichische Gesellschaft für Public HealthEuropean Public Health Association (EUPHA)

Facebook

Give us your professional opinion

Start survey

Start survey